5 completed. 4 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow ibuprofen arginine: new trials by email Literature Review of ibuprofen arginine trials Research Report on ibuprofen arginine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pain Reduction Caused by the Combined Treatment of Physiotherapy, Oral Gabapentin and Oral Ibuprofen Arginine. Median nerve neural mobilization, Gabapentin 300mg, Ibuprofen Arginine - Carpal Tunnel Syndrome | Phase 4 | Completed | Universidad Europea de Madrid | 129 | 2025-02-19 | 2025-12-11 |
| Ibuprofen Arginine and Neural Mobilization Versus Ibuprofen Arginine in the Treatment of Carpal Tunnel Syndrome median nerve neural mobilization combined with oral ibuprofen arginine, Ibuprofen Arginine - Carpal Tunnel Syndrome | Phase 4 | Completed | Universidad Europea de Madrid | 76 | 2025-02-19 | 2025-12-11 |
| A Bioequivalence Study of Two Ibuprofen Arginine Granules 400 mg Formulations Under Fasting and Fed Conditions in Chinese Healthy Adult Subjects Ibuprofen arginine granules 400 mg, Ibuprofen arginine granules 400 mg (Spedifen) - Pain | Phase 1 | Completed | HALEON | 84 | 2023-04-19 | 2024-09-19 |
| Pain Reduction Produced by Different Treatments in Carpal Tunnel Syndrome Median nerve neural mobilization, Ibuprofen Arginine - Carpal Tunnel Syndrome | Phase 4 | Completed | Francisco Unda Solano | 117 | 2020-04-14 | 2025-12-10 |
| Pain Reduction and Changes in Upper Limb Function Produced by Different Treatments in Carpal Tunnel Syndrome Median nerve neural mobilization, Ibuprofen Arginine, Gabapentin - Carpal Tunnel Syndrome | Phase 4 | Completed | Francisco Unda Solano | 196 | 2019-08-01 | 2025-12-10 |
Carpal Tunnel Syndrome (4) · Agnosia (2) · Pain (2)
Francisco Unda Solano (2) · Universidad Europea de Madrid (2) · HALEON (1)
Venezuela (4) · China (1)
Francisco Unda, PhD (3) · Francisco Unda Solano, PHD (1) · Min Xu, Master (1)